AEGIRBIO RECEIVES $1.2 MILLION NIH AWARD
As previously announced, Aegirbio AB has received a phase 1 award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program for an accessibility project.During the finalisation of the terms the parties have agreed on atimeline and resources. The award grants Aegirbio $1.2 million from the NIH RADx® Tech program, which is administered by the National Institute of Biomedical Imaging and Bioengineering. This allocation is designated for the development of a digital multiplex self-test platform, with the purpose of providing vital assistance to